{ "docId": "019dd923-5ca1-7489-b639-45501f4b359b", "docSlug": "158df8627a0b9aca", "documentTitle": "Opioid Conflicts Majority Staff Report", "authorId": "McKinsey", "authorName": "U.S. House Committee on Oversight and Reform", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "portrait", "aspectRatio": 0.773, "pageNumber": 9, "pageCount": 53, "prevPage": 8, "nextPage": 10, "slideType": "appendix_disclosure", "function": "cite_precedent", "density": "dense", "nDataPoints": 0, "notes": "This appears to be a page from a formal investigative report or congressional document.", "elementsJson": [ "paragraph", "footnote" ], "metadataConfidence": 1, "imagePath": null, "slideHref": "/slides/019dd923-5ca1-7489-b639-45501f4b359b/9", "deckHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b", "deckJsonHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b.json", "deckAnchorHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b#slide-9", "components": [ { "bbox": { "h": 0.085, "w": 0.764, "x": 0.118, "y": 0.205 }, "kind": "paragraph", "text": "During this period, numerous McKinsey consultants worked for both FDA and Purdue, both officially and unofficially. Three senior McKinsey consultants—Navjot Singh, Jeff Smith, and Sastry Chilukuri—highlight this crossover and the unclear boundaries between consultants not directly staffed on projects. Another McKinsey senior partner, Arnab Ghatak, played a key role at Purdue and appears to have contributed to work prepared for incoming HHS Secretary Alex Azar, although he did not work directly for FDA.", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "01a23093-b67d-464a-95bc-c5bc7f2c5cff", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.115, "w": 0.764, "x": 0.118, "y": 0.362 }, "kind": "paragraph", "text": "McKinsey Senior Partner Navjot Singh is one of McKinsey's lead consultants to FDA. Internal McKinsey emails obtained by the Committee show that he also participated unofficially in Purdue matters. In a 2021 FDA subcontract, McKinsey describes Mr. Singh as possessing '10 years of experience driving cross-Center collaboration for FDA, having led 80+ engagements at the Agency.'12 Of the 37 FDA contracts for which McKinsey provided staffing information to the Committee, Mr. Singh is staffed on 35 of them.13 In addition to his work at FDA, Mr. Singh leads McKinsey's state and local work for McKinsey's public sector practice in North America.14", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "3a551a3e-a6e7-478f-94f8-645f7658911d", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.075, "w": 0.764, "x": 0.118, "y": 0.118 }, "kind": "paragraph", "text": "strategy to regulatory advice. Documents indicate that in April 2008, McKinsey ratcheted up its consulting work for Purdue after the manufacturer and several senior executives pled guilty to federal charges of misbranding OxyContin.10 In 2009, one McKinsey consultant sent an email to colleagues referring to McKinsey's 'mini 'army' here at Purdue.'11", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "6ccf5173-2180-4ae6-8812-84483336e2ee", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.105, "w": 0.764, "x": 0.118, "y": 0.49 }, "kind": "paragraph", "text": "Documents show Mr. Singh played a key role in McKinsey's efforts to renew its relationship with Purdue in November 2007, advising the lead McKinsey consultants pitching Purdue, attending meetings with Purdue executives—including Purdue's then-CEO—on the company's research and development organization, and producing slides for pitch presentations.15 In one email exchange in December 2007, Mr. Singh told a McKinsey colleague that he would try to join a call for Purdue, but would be 'in transit to a meeting at the FDA.'16 In another email with the subject: 'Help on Purdue page,' Mr. Singh stated: 'I am now going to", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "99edfe4c-d2ad-4acc-8f00-0b10b1daec7f", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.15, "w": 0.764, "x": 0.118, "y": 0.69 }, "kind": "source-note", "text": "10-16 citations detailing specific documents and sources.", "attrs": { "numbered": true }, "subkind": null, "toolName": null, "toolSlug": null, "confidence": null, "componentId": "5427be6d-8f73-4a52-ac32-95bb8d6c7052", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.02, "w": 0.125, "x": 0.175, "y": 0.325 }, "kind": "title", "text": "Navjot Singh", "attrs": null, "subkind": "headline", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "ad5712a8-316b-4674-83a1-f574f1ff84a6", "frameworkName": null, "frameworkSlug": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 28, "from": 6, "beatId": "ca9c3ab4-903c-4ff0-b53d-42335d2ce596", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The document presents extensive evidence of McKinsey's conflicts of interest, including consultant overlaps and contract details.", "position": 1, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "loops": [ { "to": 53, "from": 1, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "ee9686db-f8b5-4bc9-bf6e-2d29966ee033", "evidence": "The document implies the cost of inaction through its presentation of McKinsey's conflicts of interest and their potential impact on the opioid epidemic.", "position": 0, "objective": "What is the cost of inaction in addressing McKinsey's conflicts of interest?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }